114 Sex-Specific Role of SMARCB1 in Gliomagenesis

View at publisher Summarise with VIRAT
Authors: Adham F. Halaoui, Najla Kfoury, Thomas Beaumont
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Glioblastoma (GBM) is the most common primary malignant brain tumor and has pronounced sex disparities with higher incidence and worse prognosis in males. SMARCB1, a BAF chromatin remodeling complex subunit with tumor-suppressive activity, may significantly contribute to observed sex-specific outcomes. METHODS: BAF complex subunit expression was profiled in 20 human glioma specimens spanning WHO grades. Using a syngeneic murine GBM model, BAF subunit expression and complex assembly were assessed with RNA-seq and IP-MS, respectively, in male and female tumor cells. CRISPRi knockdown of Smarcb1 was performed in male and female GBM cell lines, and the associated phenotypes were evaluated with cell-growth, clonogenicity, and temozolomide (TMZ) viability assays. Transcriptome analysis was performed with RNA-seq followed by gene-set enrichment analysis (GSEA). Multi-omic profiling (DNA methylation, Hi-C, ATAC-seq, ChIP-seq) is ongoing and will resolve sex-specific epigenomic regulation after SMARCB1 loss. RESULTS: SMARCB1 was significantly downregulated in high v. low-grade human gliomas, and IDH wild-type v. IDH-mutant. in our murine GBM model, BAF subunit expression and complex assembly were confirmed in both sexes. SMARCB1 knockdown produced opposite effects, with increased proliferation and clonogenicity in male tumor cells, and senescence in female cells. RNA-seq revealed sex-specific transcriptional reprogramming, with strong enrichment of proliferation- and oncogenesis-associated pathways in males (NES = 2.08–2.19, FWER < 0.001) and tumor-suppressive pathways in females (NES = 1.73–2.72, FWER = 0). Basal MGMT expression was three-fold higher in male cells and this difference was further amplified by SMARCB1 loss that silenced MGMT expression in female cells. Concordantly, female cells exhibited 30% greater intrinsic sensitivity to TMZ, whereas elevated MGMT expression correlated with TMZ resistance in males. CONCLUSIONS: SMARCB1 exerts a strong sex-specific influence on gliomagenesis whereby loss promotes oncogenic programs and TMZ resistance in male cells, while supressing proliferation in female cells. Patient sex and SMARCB1 status thus merit consideration as prognostic and therapeutic biomarkers in GBM.

Fields of Study & Subjects

Chromatin Remodeling and Cancer Glioma Diagnosis and Treatment Neurofibromatosis and Schwannoma Cases

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
15–15
Publication date
26 March 2026
Language
EN